Taking cognisance of the Hindustan Times report on a doctor of the Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, owning a pharmaceutical company, institute’s director Dr YK Chawla has marked an inquiry.
According to official sources, after HT’s exclusive report “PGI doctor a partner in pharma company, prescribes its medicines” was published on November 7, the PGIMER director referred the matter to the chief vigilance officer of the institute. Following the fact finding done by the vigilance cell, it recommended an inquiry against Dr Vishal Kumar, assistant professor, department of orthopaedics, PGIMER.
Following vigilance cell’s report, Dr Chawla constituted a committee under the chairmanship of Dr RK Vasishta, head, histopathology department of the institute. The other members of the committee include Sushil Thakur, financial adviser of the institute, and Dr Mahesh Devnani, assistant professor, hospital administration, PGIMER.
HT had highlighted that how in sheer violation of professional ethics as well as service rules, Dr Kumar, along with six other partners, formed a company named ‘Xenophill Pharmaceutical Limited’.
As per the memorandum of association which was prepared and signed in Delhi on June 16, 2011, Dr Vishal and others formed a company. The company, which is registered with the ministry of corporate affairs, produces antibiotics and calcium which are commonly prescribed at the PGIMER’s Advanced Trauma Centre, where Dr Kumar is posted currently.
In the partnership deed, Dr Kumar’s name has been listed on serial number seven. He has been mentioned as a professional, who is a well-known doctor and has served as the president of Association of Resident Doctors of the PGIMER.